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1002-98 Platelet-Derived Growth Factor Signaling Has a Crucial 
Role in Vascular Maturation Following Myocardial 
Infarction
Pawel T. Zymek, Kamal Nasser, Sophia Tincey, Guofeng Ren, Marcin Dobaczewski, 
Lloyd H. Michael, Mark L. Entman, Nikolaos G. Frangogiannis, Baylor College of 
Medicine, Houston, TX
Background: During the maturation phase of healing, infarct microvessels are coated by
pericytes, whereas uncoated vessels regress. Acquisition of a muscular coat leads to for-
mation of a mature vasculature preventing uncontrolled angiogenesis and decreasing
leukocyte extravasation. Platelet Derived Growth Factor (PDGF) is crucial for coating of
developing fetal vessels with pericytes. Accordingly, we examined the role of PDGF in
maturation of infarct neovessels.
Methods: A canine and a murine model of reperfused infarction were used. In vitro exper-
iments examined the effects of PDGF stimulation on isolated canine endothelial cells. To
study the role of PDGF in infarct healing, mice undergoing infarction protocols were
injected daily with neutralizing anti-PDGF antibody, or vehicle and were sacrificed after 7
days of reperfusion.
Results: Canine infarcts showed a progressive increase in the number of pericyte-coated
vessels after 2-4 weeks of reperfusion. In murine infarcts the healing rate is faster and
maturation of the vasculature occurred after 7 days of reperfusion. PDGF expression was
localized in infarct microvessels, whereas many PDGF Receptor b expressing pericytes
were identified in dog infarcts after 5-14 days and in mouse infarcts after 3-7 days of rep-
erfusion. PDGF neutralization induced significant morphological alterations of the infarct
microvasculature leading to formation of a higher number of large uncoated vessels
(p<0.05) and a lower capillary density. Uncoated vessels in PDGF antibody-treated ani-
mals were dilated and irregular and were associated with areas of red blood cell and
inflammatory leukocyte extravasation, suggesting increased permeability. PDGF-stimu-
lated endothelial cells had increased expression of the extracellular matrix cross-linking
enzyme tissue transglutaminase, supporting a role for PDGF in endothelial basement
membrane stabilization.
Conclusions: PDGF expression in healing infarcts has a critical role in vascular coating
and maturation and is important for stabilization of the scar. PDGF inhibition leads to for-
mation of a chaotic hyperpermeable vasculature and results in prolonged extravasation
of blood cells into the infarct.
1002-99 Interleukin Converting Enzyme Inhibition Reduces 
Endoplasmic Reticulum (ER) Stress and Attenuates ER 
Stress Associated Death Signals in Ventricular 
Myocardium From Post Myocardial Infarction Rats
Y. Chandrashekhar, Ruth Anway, Soma Sen, Inder Anand, VAMC/University of 
Minnesota, Minneapolis, MN
Background: Ischemia or cytokines cause Endoplasmic Reticulum (ER) stress which trig-
gers the Unfolded Protein Response (UPR). Prolonged UPR mediates cell death. It is not
clear if this happens during heart failure (HF).
Hypothesis: Since cytokine activation is common in HF, UPR & UPR mediated death sig-
nals should be active in the failing myocardium. Interleukin converting enzyme (ICE) is
important for cytokine maturation & ICE inhibition [ICE-I] might thus reduce UPR & atten-
uate apoptosis.
Methods: We measured cytoplasmic Bip/GRP78 (a marker for ER stress), ERP57 (which
reduces ER stress) & CHOP (which initiates apoptotic signaling specifically after ER
stress) levels (western blot) in rats with MI given ICE-I, [zAsp-DCB, 1 mg/day x 30, n=12]
or vehicle [V] (n=9). This was correlated with cytochrome C release, apoptosis & ventric-
ular remodeling (Echo & Hemodynamics).
Results: Infarcts were 35±6% & comparable in both groups. Bip & CHOP levels were
high in [V] compared to sham suggesting chronically activated UPR & increased apop-
totic signaling. ICE-I significantly reduced myocardial Bip & CHOP levels & improved
ERP 57. ICE-I also reduced cytochrome C release, attenuated apoptosis and was asso-
ciated with improved LV remodeling & systolic function.
Conclusions: We show for the first time, that the failing heart manifests ER stress & UPR
associated death signaling. This could worsen remodeling. ICE-I reduces these adverse
events & attenuates apoptosis. ICE-I may have important therapeutic implications.
1002-100 Tyrosine Kinase-Dependent Mechanism Occurs 
Downstream of Protein Kinase C Activation in the 
Pharmacological Preconditioning by Alpha-1 
Adrenoceptor Stimulation
Shinji Okubo, Yujirou Tanabe, Ryoko Satho, Yachiyo Hoshiba, Kenji Takeda, Michihiko 
Kitayama, Seiyu Kanemitsu, Hiroichi Tsugawa, Noboru Takekoshi, Kanazawa Medical 
University, Uchinada, Japan
Recent evidence suggests that alpha-adrenergic receptor activation induced cardiopro-
tection via protein kinase C (PKC)-sensitive pathway. We hypothesized that tyrosine
phosphorylation may be involved in the cardioprotection induced by activation of alpha-
adrenergic receptor. All rabbits were subjected to regional ischemia by 30 minutes LAD
occlusion followed by 3 hours of reperfusion. Risk area (RA) was determined by injection
of 50% Unisperse blue and infarct size (IS) was determined by computer morphometry of
tetrazolium stained sections. Infarct size was expressed as a percent of area risk (%IS/
AR).IS reduced significantly from 42±2 % in the control to 24±2 % in a alpha-adrenergic
receptor agonist, phenylephrine (25 µg/kg i.v )-treated rabbits (p<0.01). IS limitation by
phenylephrine was completely abolished by a PKC inhibitor, chelerythrine (5mg/kg, i.v;
%IS/AR, 49 ± 4) or non-specific tyrosine kinase (TK) inhibitor, genistein (5mg/kg, i.v;
%IS/AR, 46±5 ). Similarly, IS limitation by phenylephrine was completely blocked by spe-
cific TK inhibitor, lavendustin A (1 mg/kg, i.v; %IS/AR, 49±3). On the other hand, the car-
dioprotection (%IS/AR, 20 ± 3 ) by a combined injection of phenylephrine and PKC
activator, 4β-phorbol 12-myristate 13-acetate (PMA:4µg/kg, i.v ) was shown significantly
(p<0.01) . However, this cardioprotection was abolished by genistein (%IS/AR, 45 ± 4) or
lavendustin A (%IS/AR, 47± 5). On the other hand, an inactive structural analog of
genistein, daidzein (5mg/kg, i.v) did not attenuate the IS limitation by phenylephrine
(%IS/AR, 22 ± 3) or a combined injection of phenylephrine and PMA (%IS/AR, 20 ± 5). In
contrast, IS limitation effect by phenylephrine was completely abolished by a combined
injection of chelerythrine and daidzein (%IS/AR, 48 ± 3). These results suggested that
alpha-adrenergic receptor stimulation limits infarct size by a tyrosine phosphorylation
sensitive mechanism and TK plays as downstream element of PKC-mediated signal
transduction in the rabbit heart.
1002-101 Pyrroloquinoline Quinone Decreases Myocardial Infarct 
Size and Improves Cardiac Function in Rat Models of 
Ischemia and Ischemia-Reperfusion
Bo-qing Zhu, John R. Teerlink, Joel S. Karliner, VA Medical Center, San Francisco, CA, 
University of California, San Francisco, San Francisco, CA
Background: The essential nutrient pyrroloquinoline quinone (PQQ) has been newly
identified as a redox cofactor vitamin for mammals. As PQQ has been shown to act as a
free radical scavenger, we asked if PQQ is cardioprotective in rat models of ischemia and
ischemia-reperfusion. Methods: Male Sprague-Dawley rats were treated with PQQ either
before ischemia (Group 1) or before ischemia-reperfusion (Group 2). PQQ (20 mg/kg)
was given 30 min before LAD occlusion by i.p. injection. Controls received vehicle (2%
NaHCO3 1ml). Rats in Group 1 were subjected to 2 hours of LAD ligation. Rats in Group
2 were subjected to 17 min of LAD occlusion and 2 hours of reperfusion with LV hemody-
namic monitoring using a Millar catheter. Results: In Group 1, infarct size (Infarct mass/
LV mass) after PQQ was smaller than Control (10.0±1.5 vs 19.1±2.1%, P<0.01). Group 2
data are shown the table. PQQ protected against ischemia-induced cardiac dysfunction
with higher LV+dP/dt and lower LV filling pressure (LVEDP) after 1 hour of reperfusion.
There were fewer episodes of ventricular fibrillation (VF) in PQQ treated rats. Another 3
sets of Group 2 rats (10 each) received 15, 10, and 5 mg/kg of PQQ. The dose of PQQ
was inversely related to infarct size (14±2, 22±2, 29±2%, P<0.01, respectively). Conclu-
sions: PQQ given as pretreatment is highly effective in reducing myocardial infarct size
and improving cardiac function in a dose-related manner in rat models of ischemia and
ischemia-reperfusion.
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1003-85 Lack of Efficacy of Intracoronary Thrombus Aspiration 
Before Coronary Stenting in Patients With Acute 
Myocardial Infarction: A Multicenter Randomized Trial
Hiroyuki Kunii, Mikihiro Kijima, Takao Araki, Kenji Tamaki, Atsushi Katoh, Takaaki Kubo, 
Tomiyoshi Saitou, Akira Hirosaka, Hitoshi Matsuo, The NONSTOP Group, Iwaki Kyoritsu 
General Hospital, Iwaki, Japan
Background: Distal embolism of plaque or thrombotic debris is a major cause of no-
reflow or slow flow phenomena with primary stenting in patients with acute myocardial
infarction (AMI). Purpose: The aim of this study was to evaluate the safety and efficacy of
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thrombus aspiration with the Rescue PT catheter (Rescue) prior to stenting (both primary
stenting and stenting with predilation) in AMI patients. Method: Inclusion criteria were 1)
within 24 hours from onset, 2) lesion diameter > 2.5mm, 3) no severe calcification at or
proximal to the lesion, 4) no proximal tortuosity preventing Rescue use or stent delivery,
5) no cardiogenic shock, 6) no left main disease. In this mid-trial analysis, 258 patients
have been enrolled so far; 129 patients were assigned to primary stenting (Group P,
65.9+/- 11.1, 103 male) and 129 to stenting after Rescue (Group R, 64.0 +/- 11.8, 103
male), 5 were excluded. Results: In Group R, Rescue successfully crossed the culprit
lesion in 99 patients (76.7%) and successful thrombus aspiration was achieved in 90
patients (69.8%). There were no complications with the use of Rescue. However, there
was no significant difference in final TIMI III grade flow between the two groups. Conclu-
sion; Rescue could be safely used with AMI patients. This study did not show the efficacy
of Rescue in providing a protective effect against no-reflow or slow flow phenomena in
reperfusion therapy.
1003-86 Percutaneous Coronary Intervention With Distal 
Protection Device Preserves Left Ventricular Function 
in Patients With Acute Anterior Myocardial Infarction
Tomohiro Nakamura, Norifumi Kubo, Nahoko Ikeda, Takeshi Ishida, Hiroshi Funayama, 
Shigemasa Hashimoto, Takanori Yasu, Muneyasu Saito, Jichi Medical School Omiya 
Medical Center, Saitama, Japan
Background: Angiographic no-reflow phenomenon during percutaneous coronary inter-
vention (PCI) is one of poor prognostic factors in patients with acute myocardial infarction
(AMI). The aim of this study is to evaluate the effects of occlusive balloon type distal pro-
tection device (PercuSurge GuardWire®; GW) during primary stentÅ@implantation in
patients with AMI. Methods: We studied consecutive 72 patients with anterior AMI treated
by primary stent implantation. GW group included 42 patients treated by primary stent
implantation with GW protection. Control group included 30 patients trearted by primary
stent implantation after thrombectomy without distal protection. The corrected TIMI frame
count (cTFC) and myocardial blush grade (MBG) after PCI were assessed. Left ventricu-
lar (LV) function was measured and compared by left ventriculography obtained at soon
after PCI and three weeks after onset. Results: Clinical baseline characteristics were
similar between the two groups. The cTFC were lower in GW group than in control group
(27.5 ± 2.3 vs. 35.1 ± 2.5, P = 0.030). Patient numbers of MBG 3 after PCI were higher in
GW group than in control group (45.7 vs. 20.0 %, P = 0.029). Peak creatinine kinase
myocardial fraction level was lower in GW group than in control group (326.6 ± 41.5 vs.
454.9 ± 46.2 mg/dl, P = 0.043). GW group patients showed greater improvement at 3
weeks after PCI in left ventricular ejection fraction (+4.6 ± 1.2 vs. -1.1 ± 1.5, P = 0.004)
and in left ventricular end-systolic volume index (+0.5 ± 2.4 vs. +9.0 ± 2.7, P = 0.023) and
in regional wall motion abnormalities (-2.03 ± 0.14 vs. -2.51 ± 0.14, P = 0.018). Concul-
sion: PCI with GW protection could not only restore epicardial coronary flow and myocar-
dial perfusion, but also preserve left ventricular function in anterior AMI.
1003-87 Reperfusion Time-Dependent Myocardial Salvage in 
Patients With Acute Myocardial Infarction Who Undergo 
Emergent Percutaneous Coronary Intervention With 
Distal Protection Device PercuSurge
Hiroaki Mukawa, Takahito Sone, Hideyuki Tsuboi, Itsuro Morishima, Masahiko Satoda, 
Michitaka Uesugi, Ogaki Municipal Hospital, Ogaki, Japan
Purpose; Time-dependent myocardial salvage demonstrated in the experimental animal
model is rarely observed in clinical settings. The distal embolism and the microcirculation
injury caused by PCI itself may be attributed to this discrepancy. We investigated the
impact of distal protection during emergent PCI on myocardial salvage and the relation-
ship between reperfusion time and myocardial salvage in patients with acute myocardial
infarction.
Method; Patients with acute myocardial infarction were immediately treated by oral aspi-
rin and intravenous heparin, and underwent PCI with distal protection using PercuSurge
(P group; n=32) or without distal protection (C group; n=190). Risk area and infarct area
were assessed by radionuclide ventriculography using quantitative perfusion SPECT
(QPS), and myocardial salvage volume (risk area-infarct area) and salvage index (myo-
cardial salvage / risk area) were calculated.
Results; TIMI 3 flow at first angiogram was observed in 7.4% in P group and in 18.8% in
C group. PCI was performed successfully in all patients. Stent was implanted in 75.8%,
83.3%, respectively. Reperfusion time in P group was significantly longer than in C group
(405.2 vs. 218.2 min, respectively). There were not significant differences in risk area, inf-
arct area and myocardial salvage volume between both groups. However, salvage index
was higher in P group despite of longer reperfusion time (67.3% in P group vs. 62.6% in
C group, not significantly). Moreover, significant correlation between reperfusion time and
salvage index was observed in P group (R=0.604, P=0.036), but only tendency was
observed in C group.
Conclusion; Distal protection during emergent PCI may reduce myocardial damage
caused by PCI itself and achieve clearly time-dependent myocardial salvage.
1003-88 Impact of Angioplasty With Distal Protection Device on 
Myocardial Reperfusion
Mamoru Nanasato, Haruo Hirayama, Takashi Muramatsu, Kazumasa Unno, Masayuki 
Shimano, Kunihiro Matsushita, Hiroto Takezawa, Mitsuhiro Yokota, Toyoaki Murohara, 
Nagoya Daini Red Cross Hospital, Nagoya, Japan, Nagoya University, Nagoya, Japan
Background: Several studies have shown that distal embolization plays an important
role in causing reduced coronary flow and impaired microcirculatory function in patients
with acute myocardial infarction (AMI) treated with percutaneous coronary intervention
(PCI). However, there is little information on the efficacy of a distal protection device as
an adjunctive therapy to PCI in patients with AMI.
Methods: Patients within 12 hours after the onsets of AMI were enrolled. Of 64 eligible
patients, 34 were randomly assigned to PCI with a distal protection device, GuardWire
Plus as a reperfusion therapy, and 30 were assigned to conventional PCI. Patients were
evaluated by coronary angiography and electrocardiography at admission, and thallium-
201 myocardial scintigraphy before discharge. Thallium-201 myocardial scintigraphy cal-
culated left ventricular ejection fraction (LVEF) and area of myocardial infarction as sever-
ity score. All patients gave written informed consent.
Results: Baseline data were similar in both groups. Postprocedural thrombolysis in myo-
cardial infarction (TIMI) 3 flow was obtained in all patients treated with PCI plus distal pro-
tection device, and in 92% of conventional PCI (NS). However, patients treated with PCI
plus distal protection device had significantly lower corrected TIMI frame count on the
postprocedural coronary angiography (23.7 ± 10.3 vs. 33.7 ± 20.6; p=0.04), significantly
higher occurrence of grade 3 myocardial blush (71% vs. 35%; p=0.02) and early ST-seg-
ment elevation resolution on electrocardiography (79% vs. 50%; p=0.03), significantly
higher LVEF on thallium-201 myocardial scintigraphy (51.2 ± 14.5% vs. 46.7 ± 12.2%;
p=0.02), and lower severity score (5.6 ± 6.3 vs. 10.3 ± 7.3; p=0.01).
Conclusions: Use of this distal protection device during PCI in patients with AMI was
associated with a significant improvement of coronary reperfusion compared with con-
ventional PCI. This demonstrates the value of this distal protection device to obtain better
coronary reperfusion and that the reperfusion therapy with the distal protection device
may preserve left ventricular function in patients with AMI.
1003-89 Angiographic No-Reflow Phenomenon in the Patients 
With Acute Myocardial Infarction After Percutaneous 
Transluminal Coronary Intervention
Masayoshi Oikawa, Nobuo Komatsu, Yoshitaka Shiratori, Hiroyuki Kunii, Hidetsugu 
Yamao, Shigeto Namiuti, Masafumi Sugi, Mitsuru Yui, Toshikatsu Ichihara, Yukio 
Maruyama, Iwaki Kyouritsu General Hospital, Iwaki, Japan, Fukushima Medical 
University, Fukushima, Japan
Purpose: In this retrospective study, we investigated the incidence of angiographic no-
reflow or slow flow phenomenon (no-reflow) after percutaneous transluminal coronary
intervention (PCI) in patients with acute myocardial infarction (AMI).Method : We studied
425 consecutive patients with AMI treated by PCI during the period of January, 1998 to
May, 2002.Left main disease was excluded. The patients were categorized as follows:
Group P-270 patients which were performed PCI without thrombus aspiration; Group T-
155 patients which were performed PCI after thrombus aspiration using the Rescue PT
catheter.Results: The incidence of no-reflow was 44 of 425 (10.3%).There was no signifi-
cant difference in the incidence of no-reflow between the two groups (table).Conclu-
sion:In this study,the protectve effect of thrombus aspiration against no-reflow was not
proven.
P group (N=129) R group (N=129) p value
Infarct-related vessel
LAD
LCX
RCA
59 (45.8%)
15 (11.6%)
55 (42.6%)
44 (34.1%)
21 (16.3%)
64 (49.6%)
N.S.
Final TIMI grade
III
II
< or =I
119 (92.2%)
 10 (7.8%)
 0
121 (93.8%)
 8 (6.2%)
 0
N.S.
peak CPK (IU/L)
total
LAD
LCX
RCA
2560 +/- 2119
3067 +/- 2596
2741 +/- 1690
1984 +/- 1504
2608 +/- 2818
2966 +/- 3715
2901 +/- 2735
2154 +/- 1538
N.S.
N.S.
N.S.
N.S.
In-hospital death 2 (1.6%) 2 (1.6%) N.S.
Table
Group P Group T p value
No. of pts 270 155 NS
age 66+/-11 63+/-12 NS
sex (male%) 71% 76% NS
Infarct-related vessel
LAD
LCX
RCA
122
50
98
62
27
66
NS
Final TIMI grade
TIMI<or=II
TIMI III
29 (10.8%)
241 (89.2%)
15 (9.7%)
140 (90.3%)
NS
Peak CPK (IU/L) 2355+/-2482 2962+/-2128 0.001
In-hospital death 17 (6.3%) 6 (3.9%) NS
